Mohenou Diomande
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Ferroptosis and cancer prognosis
- Cancer Genomics and Diagnostics
- Global Cancer Incidence and Screening
- Circular RNAs in diseases
- Liver Disease Diagnosis and Treatment
- Cancer Cells and Metastasis
Abstract The low overall survival rates of patients with breast cancer in sub-Saharan Africa (SSA) are driven by regionally differing tumor biology, advanced stages at diagnosis, and limited access to therapy. However, it is not known whether regional differences the composition microenvironment (TME) exist affect patients’ prognosis. In this international, multicentre cohort study, 1,237 formalin-fixed, paraffin-embedded samples, including samples “African Breast Cancer-Disparities Outcomes...
<p>Figure S1: Consort diagram of the analyzed samples</p>
<p>Figure S1: Consort diagram of the analyzed samples</p>
<p>Figure S2: TILs in SSA</p>
<p>Figure S3: Immune cell subpopulations in SSA</p>
<p>Figure S2: TILs in SSA</p>
<p>Figure S4:PD-L1 expression and cytotoxicity</p>
<p>Figure S3: Immune cell subpopulations in SSA</p>
<p>Figure S5: MHC I expression in SSA</p>
<p>Figure S4:PD-L1 expression and cytotoxicity</p>
<p>Figure S5: MHC I expression in SSA</p>
<p>Figure S6: Multivariate Cox regression analysis of patient's survival.</p>
<p>Figure S6: Multivariate Cox regression analysis of patient's survival.</p>
<p>Figure S6: Multivariate Cox regression analysis of patient's survival.</p>
<p>Figure S3: Immune cell subpopulations in SSA</p>
<p>Figure S4:PD-L1 expression and cytotoxicity</p>
<p>Figure S1: Consort diagram of the analyzed samples</p>
<p>Figure S5: MHC I expression in SSA</p>